Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women
Wednesday, June 11, 2008 - 09:42
in Health & Medicine
New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers. Women who took the drug raloxifene were less likely to develop invasive, estrogen-receptor (ER) positive breast cancer compared with women who did not take the drug. The results of the randomized controlled trial will be published in the June 10 online issue of the Journal of the National Cancer Institute.
Read the whole article on Physorg
More from Physorg
Related
- Anti-estrogen drug therapy reduces risk of invasive breast cancer in older womenTue, 10 Jun 2008, 21:49:44 EDT
- Raloxifene reduces risk of invasive estrogen-receptor positive breast cancerTue, 10 Jun 2008, 21:49:51 EDT
- HWI scientist first in world to unravel structure of key breast cancer target enzymeWed, 7 Jan 2009, 13:43:41 EST
- Low-dose estrogen shown safe and effective for metastatic breast cancerTue, 18 Aug 2009, 16:32:01 EDT
- Previously unseen switch regulates breast cancer response to estrogenThu, 8 May 2008, 15:07:32 EDT